Carmell Corp

Alpha Healthcare Acquisition Corp III (Nasdaq: ALPA) was a healthcare-focused special purpose acquisition company sponsored by Alpha Healthcare Advisors that completed its business combination with Carmell Corp, a regenerative medicine and biologics company. ALPA conducted its initial public offering in 2021 and targeted the broader healthcare and life sciences sector. The merger was announced on January 4, 2023, and the transaction has since closed, making Carmell Corp a publicly traded entity. The deal represented one of several healthcare-sector SPAC combinations announced during a period of selective de-SPAC activity following the market contraction of 2022. Sign up at SpacDesk for complete filing history, warrant data, and deal analytics on ALPA and hundreds of other SPACs.

SPAC Counterparty (1)